Development
SOPHiA GENETICS SA
SOPH
$3.13
$0.082.62%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 27.38% | 39.96% | 29.03% | 28.59% | 22.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.38% | 39.96% | 29.03% | 28.59% | 22.37% |
| Cost of Revenue | 37.16% | 15.50% | 23.72% | 2.91% | -8.60% |
| Gross Profit | 23.56% | 54.57% | 31.85% | 44.47% | 41.00% |
| SG&A Expenses | 16.83% | -5.55% | -7.36% | -11.59% | -15.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 45.54% | -967.44% | 81.61% | -258.33% | -212.50% |
| Total Operating Expenses | 26.67% | -6.91% | -1.80% | -7.33% | -10.97% |
| Operating Income | -26.03% | 30.01% | 16.74% | 22.92% | 28.37% |
| Income Before Tax | -69.04% | 42.24% | 13.63% | 22.42% | 35.02% |
| Income Tax Expenses | 103.10% | 384.76% | 1,316.67% | -54.08% | 50.86% |
| Earnings from Continuing Operations | -72.22% | 40.69% | 13.31% | 22.71% | 34.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -72.22% | 40.69% | 13.31% | 22.71% | 34.64% |
| EBIT | -26.03% | 30.01% | 16.74% | 22.92% | 28.37% |
| EBITDA | -25.63% | 33.79% | 19.15% | 27.00% | 29.12% |
| EPS Basic | -70.04% | 41.50% | 13.87% | 23.14% | 34.99% |
| Normalized Basic EPS | -67.56% | 43.03% | 14.17% | 22.83% | 35.55% |
| EPS Diluted | -70.04% | 41.50% | 13.87% | 23.14% | 34.99% |
| Normalized Diluted EPS | -67.56% | 43.03% | 14.17% | 22.83% | 35.55% |
| Average Basic Shares Outstanding | 1.26% | 1.37% | 0.64% | 0.55% | 0.57% |
| Average Diluted Shares Outstanding | 1.26% | 1.37% | 0.64% | 0.55% | 0.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |